Genvax Technologies, Inc.
Genvax Technologies is a startup animal vaccine company based in Ames, Iowa, focused on developing next-generation mRNA and nanoparticle vaccines for animal health. Co-founded by Joel Harris and Dr. Hank Harris, the company aims to create innovative vaccines for the prevention and treatment of animal diseases, with a mission to accelerate breakthrough solutions in the animal health industry and make a positive global impact.
Industries
Nr. of Employees
small (1-50)
Products
mRNA + nanoparticle vaccine platform
A platform combining mRNA vaccine constructs with nanoparticle delivery systems designed for livestock vaccines, intended to enable rapid variant updates and integration with existing distribution channels.
mRNA + nanoparticle vaccine platform
A platform combining mRNA vaccine constructs with nanoparticle delivery systems designed for livestock vaccines, intended to enable rapid variant updates and integration with existing distribution channels.
Services
Custom vaccine development for livestock
Collaborative development of herd- or customer-specific vaccine formulations for livestock disease prevention and treatment, including formulation and platform integration.
Nanoparticle vaccine formulation services
Development and formulation of nanoparticle-based delivery systems for nucleic-acid vaccines intended for animal health applications.
Vaccine platform and data traceability integration
Provision of a vaccine platform that supports custom vaccine configurations and captures traceable data to support deployment and product lifecycle management.
Custom vaccine development for livestock
Collaborative development of herd- or customer-specific vaccine formulations for livestock disease prevention and treatment, including formulation and platform integration.
Nanoparticle vaccine formulation services
Development and formulation of nanoparticle-based delivery systems for nucleic-acid vaccines intended for animal health applications.
Vaccine platform and data traceability integration
Provision of a vaccine platform that supports custom vaccine configurations and captures traceable data to support deployment and product lifecycle management.
Expertise Areas
- Animal / veterinary vaccine development
- mRNA vaccine development
- Nanoparticle formulation for delivery
- Vaccine platform engineering for custom formulations
Key Technologies
- mRNA vaccine technology
- Nanoparticle delivery systems
- Vaccine platform engineering
- Cold-chain compatible formulations